<DOC>
	<DOC>NCT00723840</DOC>
	<brief_summary>This observational study will evaluate the social cost and quality of life of participants who have had Crohn's Disease for at least 6 months and have active disease despite drug therapy. Participants are followed for a total of 18 months.</brief_summary>
	<brief_title>Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560)</brief_title>
	<detailed_description>Participants for this study will be enrolled from 25 gastroenterology sites, even spread across Italy. Each center will enroll between 10 and 40 participants each.</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>participant must: be between 18 and 70 years of age, have active Crohn's disease (CD) with CDAI score &gt;= 150 (as per amended protocol) in spite of drug therapy, or active fistulizing disease, be diagnosed with CD for at least 6 months, sign the informed consent, be capable of understanding the study and replying to the questionnaires. Participants who are unreliable in filling out questionnaires, Participants with diseases which may interfere with the cost's of CD or its complications, Participants who are participating in a clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>EuroQOL (EQ-5D)</keyword>
</DOC>